Strategic Initiative

Slingshot members are tracking this corporate initiative:

Ipsen (IPSEY) Completes Acquisition of Clementia Pharmaceuticals (CMTA)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
IPSEY Community voting in process
CMTA Community voting in process

Additional Information

Additional Relevant Details
Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult and pediatric patients
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Apr 18, 2019
Projected Implementation:
Q2, 2019
Relevance Tracked Until:
Q3, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Acquisiton, Palovarotene